Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.
Oxford JS, Manuguerra C, Kistner O, Linde A, Kunze M, Lange W, Schweiger B, Spala G, Rebelo de Andrade H, Pérez Breña PR, Beytout J, Brydak L, Caraffa de Stefano D, Hungnes O, Kyncl J, Montomoli E, Gil de Miguel A, Vranckx R, Osterhaus A. Oxford JS, et al. Among authors: montomoli e. Vaccine. 2005 Nov 16;23(46-47):5440-9. doi: 10.1016/j.vaccine.2004.10.053. Vaccine. 2005. PMID: 16168526
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.
Ehrlich HJ, Müller M, Oh HM, Tambyah PA, Joukhadar C, Montomoli E, Fisher D, Berezuk G, Fritsch S, Löw-Baselli A, Vartian N, Bobrovsky R, Pavlova BG, Pöllabauer EM, Kistner O, Barrett PN; Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team. Ehrlich HJ, et al. Among authors: montomoli e. N Engl J Med. 2008 Jun 12;358(24):2573-84. doi: 10.1056/NEJMoa073121. N Engl J Med. 2008. PMID: 18550874 Free article. Clinical Trial.
A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.
Ehrlich HJ, Müller M, Fritsch S, Zeitlinger M, Berezuk G, Löw-Baselli A, van der Velden MV, Pöllabauer EM, Maritsch F, Pavlova BG, Tambyah PA, Oh HM, Montomoli E, Kistner O, Noel Barrett P. Ehrlich HJ, et al. Among authors: montomoli e. J Infect Dis. 2009 Oct 1;200(7):1113-8. doi: 10.1086/605608. J Infect Dis. 2009. PMID: 19712040 Clinical Trial.
Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.
Carraro G, Naso A, Montomoli E, Gasparini R, Camerini R, Panatto D, Tineo MC, De Giorgi L, Piccirella S, Khadang B, Ceracchi M, De Rosa A. Carraro G, et al. Among authors: montomoli e. Vaccine. 2012 Feb 1;30(6):1170-80. doi: 10.1016/j.vaccine.2011.12.014. Epub 2011 Dec 14. Vaccine. 2012. PMID: 22178096
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.
Faenzi E, Zedda L, Bardelli M, Spensieri F, Borgogni E, Volpini G, Buricchi F, Pasini FL, Capecchi PL, Montanaro F, Belli R, Lattanzi M, Piccirella S, Montomoli E, Ahmed SS, Rappuoli R, Del Giudice G, Finco O, Castellino F, Galli G. Faenzi E, et al. Among authors: montomoli e. Vaccine. 2012 Jun 8;30(27):4086-94. doi: 10.1016/j.vaccine.2012.04.020. Epub 2012 Apr 19. Vaccine. 2012. PMID: 22521851
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Svindland SC, Pedersen GK, Pathirana RD, Bredholt G, Nøstbakken JK, Jul-Larsen Å, Guzmán CA, Montomoli E, Lapini G, Piccirella S, Jabbal-Gill I, Hinchcliffe M, Cox RJ. Svindland SC, et al. Among authors: montomoli e. Influenza Other Respir Viruses. 2013 Nov;7(6):1181-93. doi: 10.1111/irv.12056. Epub 2012 Nov 21. Influenza Other Respir Viruses. 2013. PMID: 23170900 Free PMC article.
211 results